Generic Opioid Drug Manufacturer Agrees To $272.5M Multistate Settlement

(May 6, 2024, 10:25 AM EDT) -- NEW YORK — The New York attorney general on May 3 announced that generic opioid manufacturer Amneal Pharmaceuticals has agreed to a multistate settlement for its role in the nationwide opioid crisis by failing to monitor and report suspicious orders....

Related Sections